RECRUITING

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.

Official Title

Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women

Quick Facts

Study Start:2023-07-25
Study Completion:2027-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05547048

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 59 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * cis-women
  2. * have access to a working mobile or landline phone
  3. * CJ-involved (currently on probation, parole, intensive pretrial or community supervision, or are within 12 months after release from prison/jail
  4. * are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test
  5. * meet clinical criteria for PrEP
  6. * have opioid use disorder (regardless of baseline treatment status)
  1. * unable or unwilling to provide informed consent
  2. * pregnant or breast-feeding
  3. * currently taking PrEP at the time of study enrollment
  4. * not comfortable conversing in English or Spanish.

Contacts and Locations

Study Contact

Adrienne L Marable
CONTACT
(203) 737-3393
gcat5@yale.edu

Principal Investigator

Carolina Price, MPA
STUDY_DIRECTOR
Yale University
Jaimie P Meyer, MD, MS, FACP
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

University of Alabama in Birmingham
Birmingham, Alabama, 35294
United States
Yale University
New Haven, Connecticut, 06519
United States

Collaborators and Investigators

Sponsor: Yale University

  • Carolina Price, MPA, STUDY_DIRECTOR, Yale University
  • Jaimie P Meyer, MD, MS, FACP, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-25
Study Completion Date2027-04-01

Study Record Updates

Study Start Date2023-07-25
Study Completion Date2027-04-01

Terms related to this study

Additional Relevant MeSH Terms

  • HIV
  • Opioid Use Disorder
  • eHealth